8/ 🧩 Conclusion:
PIRs tailored for local settings, like mCALGB, are game-changers for AYA ALL in LMICs. This study underscores the importance of context-appropriate adaptations in global hematólogo.
1/ 📢 Let’s dive into a crucial topic in #Hematology: How do adult regimens compare with pediatric-inspired regimens (PIRs) for Philadelphia-negative ALL? Our study from Mexico offers some insights #ALL@RobertaDemiche3@faustor@rajuan_27@analymorac
https://t.co/b8ydOWFbg5
7/ 🚧 Challenges:
•Need for data on Ph-like ALL in Hispanic populations
•Limited access to stem cell transplant and novel therapies like blinatumomab in LMICs
So glad to see the results of PI regimens implementation in our country by @RobertaDemiche3. Important data that encourages ALL research in LATAM @SocietyofHemOnc.
A comparative study of Hyper-CVAD and mCALGB-10403 in adults with Ph negative ALL 🩸#ASH23 My first ASH as hematology resident, such a great experience @ASH_hematology thanks to my mentor and the entire work team @RobertaDemiche3@faustor@analymorac
Es justo y necesario. La vacuna covid que está llegando a México es escasa; debe aplicarse con prioridad al personal de salud que está atendiendo a los pacientes con Covid.